{"url_path":"/sec/fblg/8-k/2026-07-09/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-09","source_url":"https://www.sec.gov/Archives/edgar/data/1958777/0001193125-26-299290-index.html","accession_number":"0001193125-26-299290","cik":"0001958777","ticker":"FBLG","issuer_name":"FibroBiologics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1958777/0001193125-26-299290-index.html","primary_entity_key":"0001958777","primary_entity_name":"FibroBiologics, Inc."},"word_count":71,"has_tables":true,"body_markdown":"## Item 9.01 Financial Statements and Exhibits.\n\n \n\n[Exhibit 99.1](fblg-ex99_1.htm)\n\n[Press Release](fblg-ex99_1.htm)\n\nExhibit 104\n\nCover Page Interactive Data File (embedded within the inline XBRL document)\n\n \n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\nFibroBiologics, Inc.\n\n \n\n \n\n \n\n \n\nDate:\n\nJuly 9, 2026\n\nBy:\n\n/s/ Pete O'Heeron\n\n \n\n \n\n \n\nName: Pete O'Heeron\nTitle: Chief Executive Officer"}